BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11151935)

  • 1. Mycophenolate mofetil for therapy-resistant interstitial lung disease associated with ulcerative colitis.
    Treiber G
    Am J Gastroenterol; 2000 Dec; 95(12):3674-5. PubMed ID: 11151935
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
    Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.
    Saketkoo LA; Espinoza LR
    Arch Intern Med; 2008 Aug; 168(15):1718-9. PubMed ID: 18695091
    [No Abstract]   [Full Text] [Related]  

  • 4. Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.
    Gómez-Puerta JA; Espinosa G; Morlà R; Cid MC; Cervera R
    Clin Exp Rheumatol; 2009; 27(1):166-7. PubMed ID: 19327249
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
    Hayashi M; Kikuchi T; Takada T
    Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of pemphigus vulgaris with mycophenolate mofetil.
    Enk AH; Knop J
    Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil as induction therapy after liver transplantation.
    McDiarmid SV
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
    Zimmer-Molsberger B; Knauf W; Thiel E
    Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil, Crohn's disease, measles?
    Altschuler EL
    Am J Gastroenterol; 2000 Feb; 95(2):550-1. PubMed ID: 10685769
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C; Honma N; Tanaka R; Oh-ishi T
    Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.
    Zamora AC; Wolters PJ; Collard HR; Connolly MK; Elicker BM; Webb WR; King TE; Golden JA
    Respir Med; 2008 Jan; 102(1):150-5. PubMed ID: 17822892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
    Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
    Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.
    Hauser RA; Malek AR; Rosen R
    Neurology; 1998 Sep; 51(3):912-3. PubMed ID: 9748061
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome.
    Schneider C; Gold R; Schäfers M; Toyka KV
    Muscle Nerve; 2002 Feb; 25(2):286-8. PubMed ID: 11870700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil.
    Griesmacher A; Weigel G; Seebacher G; Mallinger R; Laufer G; Müller MM
    Adv Exp Med Biol; 1998; 431():537-41. PubMed ID: 9598124
    [No Abstract]   [Full Text] [Related]  

  • 16. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.
    Schütz E; Shipkova M; Armstrong VW; Wieland E; Oellerich M
    Clin Chem; 1999 Mar; 45(3):419-22. PubMed ID: 10053049
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
    Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis.
    Altschuler EL
    Med Hypotheses; 2001 Dec; 57(6):701-2. PubMed ID: 11918429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.